These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23172896)

  • 1. Optimizing transition of care through the facilitation of a pharmacist-managed deep vein thrombosis treatment program.
    Davis KA; Miyares MA; Price-Goodnow VS
    J Pharm Pract; 2013 Aug; 26(4):438-41. PubMed ID: 23172896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating anticoagulation for safer transitions: preliminary outcomes from an emergency department deep vein thrombosis discharge program.
    Falconieri L; Thomson L; Oettinger G; Pugliese R; Palladino M; Galanis T; Merli G
    Hosp Pract (1995); 2014 Oct; 42(4):16-45. PubMed ID: 25502127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
    Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
    J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome analysis of a pharmacist-managed anticoagulation service.
    Wilt VM; Gums JG; Ahmed OI; Moore LM
    Pharmacotherapy; 1995; 15(6):732-9. PubMed ID: 8602380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM; Cummins G; Taylor DC; Russell MW
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance.
    Donovan JL; Drake JA; Whittaker P; Tran MT
    J Thromb Thrombolysis; 2006 Aug; 22(1):23-30. PubMed ID: 16786229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nine-year experience with a pharmacist-managed anticoagulation clinic.
    Conte RR; Kehoe WA; Nielson N; Lodhia H
    Am J Hosp Pharm; 1986 Oct; 43(10):2460-4. PubMed ID: 3788996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
    Amin AN; Lin J; Thompson S; Wiederkehr D
    Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient deep vein thrombosis treatment models.
    Leong WA
    Pharmacotherapy; 1998; 18(6 Pt 3):170S-174S. PubMed ID: 9853911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service.
    Schillig J; Kaatz S; Hudson M; Krol GD; Szandzik EG; Kalus JS
    J Hosp Med; 2011; 6(6):322-8. PubMed ID: 21834113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery.
    Nutescu EA; Shorr AF; Farrelly E; Horblyuk R; Happe LE; Franklin M
    Ann Pharmacother; 2008 Sep; 42(9):1216-21. PubMed ID: 18611992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Evaluation of a Pharmacist-Driven Screening Tool to Identify Patients Presenting to the Emergency Department Who Are Eligible for Outpatient Treatment of Deep Vein Thrombosis.
    Musco SE; Smallwood SM; Gossard J
    J Pharm Pract; 2021 Jun; 34(3):378-385. PubMed ID: 33969771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outpatient treatment of deep-vein thrombosis].
    Thyssen JP; Thielke D; Ørnstrup ML; Sejersen HM
    Ugeskr Laeger; 2007 Jan; 169(2):112-5. PubMed ID: 17227655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital.
    Bauer JB; Chun DS; Karpinski TA
    Am J Health Syst Pharm; 2008 Sep; 65(17):1643-7. PubMed ID: 18714111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Results from the OTIS-DVT Registry.
    Spirk D; Husmann M; Willenberg T; Banyai M; Frank U; Baldi T; Amann-Vesti B; Baumgartner I; Kucher N
    Thromb Haemost; 2011 Feb; 105(2):239-44. PubMed ID: 20886197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacists.
    Airee A; Guirguis AB; Mohammad RA
    Ann Pharmacother; 2009 Apr; 43(4):621-8. PubMed ID: 19318602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two different models of anticoagulation management services with usual medical care.
    Rudd KM; Dier JG
    Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of an emergency department-based clinical pharmacist transitions-of-care program.
    Hohner E; Ortmann M; Murtaza U; Chopra S; Ross PA; Swarthout M; Efird L; Pherson E; Saheed M
    Am J Health Syst Pharm; 2016 Aug; 73(15):1180-7. PubMed ID: 27440625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.